Pradaxa (dabigatran etexilate)
pCPA File Number:
20784
Negotiation Status:
Concluded with an LOI
Indication(s):
Atrial fibrillation prevention of stroke and systemic embolism
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
CADTH Project Number:
S0214
pCPA Engagement Letter Issued:
Negotiation Process Concluded: